Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Gastroenteritis

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...

Probiotics

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...

Colonisation of Pathogens

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...

Microbiota Modulation by Antibiotics

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...

Development of Human Microbiota

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...

Development of the Oral Microbiota

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Associations between fentanyl exposure, gut microbiome and neurodevelopmental outcomes in preterm infants.

Pediatric research·2026

Same author

Maternal trans-vaccenic acid shapes neonatal T cell development and early-life immune imprinting.

Science (New York, N.Y.)·2026

Same author

Helminth infection induces malabsorption of dietary fat via STAT6-dependent intestinal MTTP suppression.

Journal of advanced research·2026

Same author

Fecal Microbiome and Bile Acid Profiles Differ in Preterm Infants with Parenteral Nutrition-associated Cholestasis.

Journal of clinical and translational hepatology·2025

Same author

Impacts of COVID-19 pandemic on early life gut microbiome.

Gut microbes·2025

Same author

Early-life gut microbiome maturity regulates blood-brain barrier and cognitive development.

Gut microbes·2025

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

Bacterial colonization, probiotics, and necrotizing enterocolitis.

Erika C Claud¹, W Allan Walker

¹Department of Pediatrics, University of Chicago, Chicago, IL, USA.

Journal of Clinical Gastroenterology

|June 4, 2008

Summary

This summary is machine-generated.

Probiotic therapy may improve gut health in preterm infants by optimizing intestinal colonization and reducing necrotizing enterocolitis. Further research is ongoing to understand how probiotics influence the infant gut microbiome.

More Related Videos

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling

Published on: September 19, 2025

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Published on: June 8, 2022

Related Experiment Videos

Last Updated: Jul 4, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling

Published on: September 19, 2025

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Published on: June 8, 2022

Area of Science:

Neonatal medicine
Microbiology
Gastroenterology

Background:

The neonatal gut microbiome is crucial for intestinal health and function.
Preterm infants have immature defenses, making them susceptible to gut issues like necrotizing enterocolitis.
Gut colonization patterns are influenced by delivery, feeding, and medical interventions.

Purpose of the Study:

To explore the potential benefits of modulating the intestinal flora in preterm infants.
To investigate the role of probiotics in preventing or mitigating neonatal necrotizing enterocolitis.
To understand how specific bacteria influence intestinal maturation and inflammation.

Main Methods:

Review of clinical studies on probiotic therapy in preterm infants.
Analysis of factors influencing neonatal intestinal colonization.
Investigation into the mechanisms of probiotic action on the gut microbiome.

Main Results:

Clinical studies suggest probiotics may decrease the incidence of necrotizing enterocolitis.
Certain bacteria are known to promote intestinal maturation and reduce inflammation.
Probiotic therapy is a potential strategy for optimizing gut health in vulnerable infants.

Conclusions:

Modulating the intestinal flora, particularly with probiotics, shows promise for preterm infants.
Probiotics may help optimize intestinal colonization and improve outcomes.
Further research is needed to fully understand probiotic mechanisms and ensure safety.